Accounts Receivable, after Allowance for Credit Loss, Current of VitaNova Life Sciences Corp from 30 Apr 2024 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
VitaNova Life Sciences Corp quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Apr 2024 to 31 Oct 2025.
  • VitaNova Life Sciences Corp Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Oct 2025 was $882,612, a 1430% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

VitaNova Life Sciences Corp Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $882,612 +$824,912 +1430% 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 $1,014,282 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q1 2025 $1,266,951 +$1,266,951 30 Apr 2025 10-Q 15 Dec 2025 2026 Q2
Q4 2024 $54,018 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 $57,700 31 Oct 2024 10-Q 13 Dec 2024 2025 Q2
Q1 2024 $0 30 Apr 2024 10-K 24 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.